Illumina announces CEO transition plan as Francis deSouza resigns Illumina Inc. has announced that its board of directors has accepted the resignation of CEO Francis… Đọc tiếp »Illumina’s CEO Francis deSouza Resigns, Company Unveils Transition Plan for New Leadership
FDA advisors review Alzheimer’s drug Leqembi for full approval FDA Panel Meets to Discuss Full Approval of Alzheimer’s Drug Leqembi A panel of independent advisors… Đọc tiếp »FDA Experts Assess the Feasibility of Granting Full Approval to Alzheimer’s Drug Leqembi
Lawmakers press for more info on Medicare coverage Democratic Lawmakers Demand More Information on Medicare’s Coverage Plan for Alzheimer’s Treatments Democratic lawmakers Rep. Anna Eshoo… Đọc tiếp »Lawmakers demand greater clarity about Medicare coverage.
Merck sues Biden administration over Medicare drug price negotiations Drug manufacturer Merck has filed a lawsuit against the Biden administration over Medicare’s new powers to… Đọc tiếp »Biden Administration Faces Lawsuit from Merck for Medicare Drug Price Negotiations
FDA allows import of unapproved China chemo med In response to an acute shortage of cancer drugs in the United States, the US Food and… Đọc tiếp »Unapproved Chinese Chemotherapy Medication Now Allowed for Import by FDA
Singapore PM Lee tests positive for Covid again in rebound case Singapore Prime Minister Lee Hsien Loong tests positive for Covid-19 for second time Singapore… Đọc tiếp »PM Lee of Singapore retests positive for Covid in a rebound episode.
Tylenol parent Kenvue can capitalize on consumer self-care trends, JPMorgan says Kenvue, the largest pure-play consumer health company in the world, is in a prime… Đọc tiếp »JPMorgan states that Kenvue, the parent company of Tylenol, has an opportunity to benefit from the increasing trend of consumer self-care.
ASCO will focus on the cancer fight. These stocks are in the spotlight The American Society of Clinical Oncology will be hosting the world’s biggest… Đọc tiếp »Cancer battle to be the main focus at ASCO: Check out the stocks in the limelight.
Elon Musk’s Neuralink gets FDA approval for in-human study Neuralink, the neurotech startup co-founded by Elon Musk, has received approval from the Food and Drug… Đọc tiếp »In-Human Study of Elon Musk’s Neuralink Receives FDA Approval
Illumina shareholders oust board chair in Carl Icahn proxy battle Carl Icahn, an activist investor, has succeeded in ousting Illumina’s board chair after obtaining enough… Đọc tiếp »Board chair removed by Illumina shareholders during proxy fight with Carl Icahn.